In vivo prooxidant state in Werner syndrome (WS): Results from three WS patients and two WS heterozygotes

Free Radical Research

Volumn 39, Issue 5, 2005, Pages 529-533

  Pagano, Giovanni ^a,i   Zatterale, Adriana ^b   Degan, Paolo ^a   D'Ischia, Marco ^c   Kelly, Frank J ^d   Pallardó, Federico V ^e   Calzone, Rita ^b   Castello, Giuseppe ^a   Dunster, Christina ^d   Giudice, Aldo ^a   Kilinç, Yurdanur ^f   Lloret, Ana ^e   Manini, Paola ^c   Masella, Roberta ^g   Vuttariello, Emilia ^a   Warnau, Michel ^h  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Elena d'Aosta Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF VALENCIA   (Spain)

^f CUKUROVA UNIVERSITY   (Turkey)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h MC 98012   (Monaco)

ⁱ CRITTOLS   (Italy)

Author keywords

Glutathione; Glyoxal; Methylglyoxal; Oxidative DNA damage; Prooxidant state; Werner syndrome

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DEOXYGUANOSINE; GAMMA TOCOPHEROL; GLUTATHIONE; GLYOXAL; METHYLGLYOXAL; URIC ACID;

ADULT; AGING; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC DISORDER; HETEROZYGOTE; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; WERNER SYNDROME;

ADULT; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; DINOPROST; FEMALE; GLUTATHIONE; GLYOXAL; HETEROZYGOTE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PYRUVALDEHYDE; WERNER SYNDROME;

EID: 21044447217     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760500092683     Document Type: Review

References (28)

1. Chen L, Oshima J. Werner syndrome. J Biomed Biotechnol 2002;2:46-54.
2. von Kobbe C, Thoma NH, Czyzewski BK, Pavletich NP, Bohr VA. Werner syndrome protein contains three structure-specific DNA binding domains. J Biol Chem 2003;278:52997-53006.
3. Imamura O, Fujita K, Itoh C, Takeda S, Furuichi Y, Matsumoto T. Werner and Bloom helicases are involved in DNA repair in a complementary fashion. Oncogene 2002;21:954-963.
4. Goto M, Yamabe Y, Shiratori M, Okada M, Kawabe T, Matsumoto T, Sugimoto M, Furuichi Y. Immunological diagnosis of Werner syndrome by down-regulated and truncated gene products. Hum Genet 1999;105:301-307.
5. Poot M, Gollahon KA, Emond MJ, Silber JR, Rabinovitch PS. Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N-oxide and 8-methoxypsoralen: Implications for the disease phenotype. FASEB J 2002;17:757-758.
6. Poot M, Yom JS, Whang SH, Kato JT, Gollahon KA, Rabinovitch PS. Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J 2001;15:1224-1226.
7. Nunoshiba T, Demple B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res 1993;53:3250-3252.
8. Pagano G, Manini P, Bagchi D. Oxidative stress-related mechanisms are associated with xenobiotics exerting excess toxicity to Fanconi anemia cells. Environ Health Perspect 2003;111:1699-1703.
9. Kashino G, Kodama S, Nakayama Y, Suzuki K, Fukase K, Goto M, Watanabe M. Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. Free Radic Biol Med 2003; 35:438-443.
10. 2. Ann NY Acad Sci 2004; 1019:375-378.
11. von Kobbe C, May A, Grandori C, Bohr VA. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. FASEB J 2004;18:1970-1972.
12. Nordenson I. Chromosome breaks in Werner's syndrome and their prevention in vitro by radical-scavenging enzymes. Hereditas 1977;87:151-154.
13. Oliver CN, Ahn B-W, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem 1987;262:5488-5491.
14. Degan P, Bonassi S, De Caterina M, Korkina LG, Pinto L, Scopacasa F, Zatterale A, Calzone R, Pagano G. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995;16:735-742.
15. Espinosa-Mansilla A, Duràn-Meràs I, Salinas F. High-performance liquid chromatographic-fluorometric determination of glyoxal, methylglyoxal, and diacetyl in urine by prederivatization to pteridinic rings. Anal Biochem 1998;255:263-273.
16. Asensi M, Sastre J, Pallardó FV, Estrela JM, Viña J. High performance liquid chromatography determination of oxidized glutathione in blood. Methods Enzymol 1994;234: 367-371.
17. Iriyama K, Yoshiura M, Iwamoto T, Ozaki Y. Simultaneous determination of uric and ascorbic acids in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Anal Biochem 1984;141: 238-243.
18. Kelly FJ, Rodgers W, Handel J, Smith S, Hall MA. Time course of vitamin E repletion in the preterm infant. Br J Nutr 1990;63:631-638.
19. Zar JH. Biostatistical analysis. 3rd ed. Upper Saddle River, NJ: Prentice-Hall; 1996.
20. Floyd RA. The role of 8-hydroguanine in carcinogenesis. Carcinogenesis 1990;9:1447-1450.
21. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002;251:87-101.
22. Lou MF. Redox regulation in the lens. Prog Retin Eye Res 2003;22:657-682.
23. Davis T, Singhrao SK, Wyllie FS, Haughton MF, Smith PJ, Wiltshire M, Wynford-Thomas D, Jones CJ, Faragher RG, Kipling D. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J Cell Sci 2003; 116:1349-1357.
24. Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE, Moser MJ, Oshima J, Russell DW, Swisshelm K, Frank S, Amati B, Dalla Favera R, Monnat RJ. Jr. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 2003;17:1569-1574.
25. Orren DK, Machwe A, Karmakar P, Piotrowski J, Cooper MP, Bohr VA. A functional interaction of Ku with Werner exonuclease facilitates digestion of damaged DNA. Nucleic Acids Res 2001;29:1926-1934.
26. Pichierri P, Rosselli F, Franchitto A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene 2003;22:1491-1500.
27. Blander G, Zalle N, Leal JF, Bar-Or RL, Yu CE, Oren M. The Werner syndrome protein contributes to induction of p53 by DNA damage. FASEB J 2000;14:2138-2140.
28. Pagano G, Degan P, d'Ischia M, Kelly FJ, Pallardó FV, Zatterale A, Anak SS, Akişik EE, Beneduce G, Calzone R, De Nicola E, Dunster C, Lloret A, Manini P, Nobili P, Saviano A, Vuttariello E, Warnau M. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients. Carcinogenesis 2004; 25:1899-1909.